vitoss

Josh SandbergDecember 9, 2010
877

Orthovita Gets FDA Clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

Orthovita, Inc., an orthobiologics and biosurgery company, said that it received 510(k) clearance from the U.S. Food and Drug Administration…
Read More »
Josh SandbergDecember 7, 2010
1,517

Orthovita Receives FDA Clearance for Vitoss™ Bioactive Foam-2X Bone Graft Substitute

MALVERN, Pa.–(BUSINESS WIRE)–Orthovita, Inc. (NASDAQ: VITA), an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the…
Read More »